Post expires at 5:26pm on Friday May 20th, 2016
With plenty of opportunity for networking and debate, this informal international meeting will bring you up to date with current research and thinking regarding cancer screening, prevention and treatment. Presenters will include Clinicians, Academics and members of the Pharmaceutical industry and we encourage presentations from the wide spectrum of cancer research, development and healthcare professionals.
This event has CPD accreditation
With plenty of opportunity for networking and debate, this informal international meeting will bring you up to date with current research and thinking regarding cancer screening, prevention and treatment. Presenters will include Clinicians, Academics and members of the Pharmaceutical industry and we encourage presentations from the wide spectrum of cancer research, development and healthcare professionals.
This event has an open abstract session.
Abstracts can be submitted on any subject related to Cancer
The Deadline for abstract submissions for oral presentation is Feb 10th 2015
Abstracts for poster presentation only can be submitted up to two weeks before the event
You can download the instructions for authors at www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf
The 2014 Controlling Cancer Summit Anti-Cancer Therapeutics Meeting report from the Euroscicon event: 14th May 2014, London, UK Meeting Chair: Dr. Ann White, Senior Research Fellow, University of Southampton, UK Author: Matthew Trendowski Department of Biology, Syracuse University, NY, USA Editor: Dr. Astrid Englezou, Euroscicon Ltd This meeting report summarizes the talks from the third […]
With plenty of opportunity for networking and debate, this informal international meeting will bring you up to date with current research and thinking regarding cancer screening, prevention and treatment. Presenters will include Clinicians, Academics and members of the Pharmaceutical industry and we encourage presentations from the wide spectrum of cancer research, development and healthcare professionals.
This year there are three main topics for discussion
Screening and Prevention Research
Biomarker Discovery and Assay Development
Anti-Cancer Therapeutics
With plenty of opportunity for networking and debate, this informal international meeting will bring you up to date with current research and thinking regarding cancer screening, prevention and treatment.
Whilst numerous challenges exist in translating biomarker research into the clinical space; a number of gene and protein based biomarkers are already being used at some point in patient care. This event will discuss the further discovery and assay development of genetic, epigenetic, proteomic, glycomic, and imaging biomarkers which can be used for cancer diagnosis, prognosis, and epidemiology. We provide an informal atmosphere for discussion and debate. This is an ideal setting for experts to present their work and discuss their findings.
This site is regularly updated with information regarding the one day Life Science events within the UK run by Euroscicon
Follow Us!